Back to search
Humoral Rejection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Humoral Rejection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Humoral Rejection trials you may qualify forThe study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR varia…
Chronic histiocytic intervillositis (CHI) is a rare condition with an incidence of 5 in 10,000 pregnancies. This rare condition is associated with placental inf…
Assessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"
Microvascular inflammation, the hallmark histological criteria of antibody-mediated rejection in kidney transplantation, remains an issue in routine practice, d…